
Anti-VEGF Injections for Retinal Conditions
Introduction to Anti-VEGF Therapy
This section explains what anti-VEGF treatment is and why it matters for retinal health.
Anti-VEGF therapy involves placing medicine inside the eye to control harmful blood vessel growth. The goal is to stop leakage, swelling, and scarring that threaten sight.
An anti-VEGF injection is an intravitreal shot, meaning the medicine goes into the gel at the center of the eye. The medicine binds to VEGF so it cannot trigger abnormal vessel growth.
Under normal conditions VEGF helps the body form new blood vessels. In retinal disease too much VEGF leads to fragile, leaky vessels that blur or distort vision. Blocking excess VEGF keeps the retina stable and can improve visual clarity.
Mechanism and Medications for Anti-VEGF Therapy
Here we look at how the medicines work and review the most common drugs used.
VEGF is found throughout the body, including the eye. When overproduced in the retina it causes vessels to form that leak fluid and blood. Anti-VEGF drugs attach to VEGF molecules, stopping them from activating cell receptors. This action limits new vessel growth and protects retinal tissue.
Three main medicines are used today. Each works in a similar way but has unique features.
- Bevacizumab (Avastin) is approved for cancer care and used off-label in the eye. It blocks VEGF effectively and is often lower in cost.
- Ranibizumab (Lucentis) was designed for eye use and is approved for several retinal conditions.
- Aflibercept (Eylea) is a newer option that binds VEGF strongly and offers similar safety and results to ranibizumab.
Procedure Details for Anti-VEGF Injections
This section describes what happens before, during, and after an injection visit.
The procedure is quick and performed in a clean clinic room.
- Pre-procedure: The eye is cleaned with antiseptic and numbing drops are applied.
- Injection: A very fine needle delivers the medicine through the white part of the eye. Most patients feel only brief pressure.
- Immediate aftercare: Vision is checked, soothing ointment may be placed, and an eye pad is worn for several hours.
You will look at a fixed target while the doctor gently keeps the eyelids open. After the shot your vision is rechecked and you can usually leave within a short time.
- Mild scratchy feelings, redness, or temporary floaters may occur and should fade within a day or two.
- Follow the care instructions given to you and avoid rubbing the eye.
Safety and Efficacy Considerations
Anti-VEGF therapy is safe for most people, yet understanding benefits and risks is important.
Serious problems are rare, especially when injections are given by trained eye specialists.
- Low risk of infection, about 1 in 2000 injections.
- Rare bleeding or retinal detachment, less than 1 in 1000 injections.
- Slight chance of cataract, inflammation, or allergy, also less than 1 in 1000 injections.
- Very small risk of stroke or heart attack has not been shown at the eye doses used.
About one third of patients gain vision and almost nine out of ten keep their current level of sight. Regular follow-up helps adjust the plan for the best outcome.
By reducing leakage and blocking new vessel growth, anti-VEGF therapy keeps the retina stable. Imaging tests such as optical coherence tomography guide future treatment choices.
Follow-Up and Medication Options
Ongoing care ensures the medicine continues to protect your vision and fits your needs.
Many conditions require repeated injections. At each visit vision is checked and imaging may be done to decide when the next dose is needed.
All three drugs offer similar results. Differences include cost, packaging, and approval status. Your doctor selects the one that best matches your medical and financial situation.
Minor redness or floaters are normal. Contact your eye care team right away if you notice any of the warning signs below.
- Severe or persistent eye pain
- Sudden drop in vision
- Marked redness or swelling
- Increase in floaters or flashes of light
Conditions Managed with Anti-VEGF Injections
These injections have changed care for several serious retinal diseases.
In wet AMD abnormal vessels grow under the macula and can quickly damage central vision. Anti-VEGF therapy slows or reverses this process.
High blood sugar harms retinal vessels and leads to leakage. Blocking VEGF reduces swelling and bleeding.
Fluid collects in the macula and blurs central sight. Anti-VEGF injections lower swelling and sharpen vision.
A blocked vein raises pressure in the retina, causing leakage. Treatment limits vessel abnormalities and protects vision.
Frequently Asked Questions
The answers below address common worries about anti-VEGF injections.
Numbing drops make the eye comfortable. Most people feel only brief pressure rather than pain.
No. The needle comes from the side, outside your line of sight, which helps reduce anxiety.
The entire visit, including preparation and aftercare, usually takes 15 to 30 minutes.
Keep the eye pad on for several hours, use any prescribed drops, avoid rubbing the eye, and watch for unusual symptoms.
Seek prompt care if you experience severe pain, sudden vision changes, significant redness, or any other concern after the injection.
Protecting Your Vision Together
Anti-VEGF injections offer a proven way to fight retinal disease and save sight. Our team is here to guide you through each step, answer questions, and tailor care to your unique needs.
